Nancy Mendenhall MD, FASTRO, Associate Chair and Medical Director of the UF Health Proton Therapy Institute, has more than 30 years of experience in Radiation Oncology specializing in breast cancer, Hodgkin disease, lymphomas, pediatric cancers, and prostate cancer. For the past 14 years her focus has been the expansion of the use of proton therapy. Prior to her current role as the Medical Director for the UF Health Proton Therapy Institute (UFHPTI) in 2006, she was Department Chair for Radiation Oncology at the UF College of Medicine, the first female Chair in the College’s history. She has trained more than 87 residents and fostered over 75 resident peer-reviewed publications. As the Editor-in-Chief of the International Journal of Particle Therapy, she helped to found the first peer-reviewed international academic journal for particle therapy. Dr. Mendenhall received a five-year, $11.9 million award in 2017 from the Patient-Centered Outcomes Research Institute which supports the research study ‘A Prospective COMparative Study of Outcomes with Proton and Photon RAdiation in PRostate CancEr (COMPPARE)’ which is a large-scale, pragmatic clinical study to compare outcomes between proton and conventional radiation in 3,000 men with prostate cancer for which she is lead Principle Investigator. She recently received the 2020 Paulus Award for Clinical Excellence from the University of Florida for ‘Making a difference for patient care; an unfailing moral compass; engagement at every level of patient care; and championing teamwork.’. She also won the University of Florida’s College of Medicine Clinical Science Researcher of the Year in 2018.
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none